NCT03692884 (CDR) is a clinical trial in Diabetes Mellitus, sponsored by Chongqing Medical University.

Who is sponsoring NCT03692884?

NCT03692884 is sponsored by Chongqing Medical University.

What condition does NCT03692884 study?

NCT03692884 studies Diabetes Mellitus.

Is NCT03692884 still recruiting?

NCT03692884 is currently recruiting now. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT03692884: CDR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chongqing Diabetes Registry Study

Recruiting now Last updated 6 September 2023

What this trial tests

trial in Diabetes Mellitus in 5,000 participants. Currently enrolling.

Timeline

1 July 2018

Primary endpoint
1 July 2030

1 July 2030

Quick facts

Lead sponsor	Chongqing Medical University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	1 July 2018
Primary completion	1 July 2030
Estimated completion	1 July 2030
Sites	1 location across China

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Chongqing Medical University

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus.
Lv L, Zhou Y, Chen X, Gong L, et al · · 2021 · cited 59× · PMID 34305401 · DOI 10.2147/dmso.s318255
Peripheral monocyte count is an independent predictor of all-cause mortality in type 2 diabetes with macro-vascular complications.
Yang L, Hu J, Wang Z, Chen X, et al · · 2020 · cited 5× · PMID 31977891 · DOI 10.1097/md.0000000000018876
Association of BMI Change with New-Onset or Progressive Diabetic Kidney Disease in People with Normal-Weight Type 2 Diabetes.
Mao L, Adnan E, Chen Z, Pan Y, et al · · 2026 · PMID 42074925 · DOI 10.3390/jcm15083125
Association between CT-based adrenal gland volume and 10-year cardiovascular disease risk in patients with diabetes mellitus.
Li C, Chen X, Li Y, Yang S, et al · · 2026 · PMID 41816070 · DOI 10.21037/qims-2025-2027
High Remnant Cholesterol is Associated with the Development of Diabetic Kidney Disease in Patients with Type 2 Diabetes.
Chen Z, Shen Y, Chen X, Hu J, et al · · 2025 · PMID 40994793 · DOI 10.2147/dmso.s542648

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other Chongqing Medical University trials

Trials by the same sponsor.

NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
NCT07503509 — Physiological Study of High PEEP in Noninvasive Ventilation · NA · recruiting
NCT06118671 — The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community · NA · unknown
NCT06272032 — Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis · EARLY_PHASE1 · unknown
NCT05974566 — Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03692884 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chongqing Medical University
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03692884.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing